We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.7B
AUM Growth
+$211M
Cap. Flow
-$755M
Cap. Flow %
-5.94%
Top 10 Hldgs %
33.79%
Holding
1,215
New
45
Increased
450
Reduced
295
Closed
31

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$108M
2
VER
VEREIT, Inc.
VER
+$105M
3
WELL icon
Welltower
WELL
+$102M
4
VTR icon
Ventas
VTR
+$88.9M
5
BXP icon
Boston Properties
BXP
+$86.8M

Sector Composition

Rank Sector Weight
1 Real Estate 73.5%
2 Industrials 3.95%
3 Technology 3.75%
4 Financials 2.75%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
1026
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
139
SPPI
1027
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$12K ﹤0.01%
556
CLVS
1028
DELISTED
Clovis Oncology, Inc.
CLVS
$12K ﹤0.01%
271
ENDP
1029
DELISTED
Endo International plc
ENDP
$12K ﹤0.01%
1,234
XLRN
1030
DELISTED
Acceleron Pharma
XLRN
$12K ﹤0.01%
250
RGEN icon
1031
Repligen
RGEN
$7.44B
$11K ﹤0.01%
241
GBT
1032
DELISTED
Global Blood Therapeutics, Inc.
GBT
$11K ﹤0.01%
241
INSM icon
1033
Insmed
INSM
$23.2B
$10K ﹤0.01%
423
NRG icon
1034
NRG Energy
NRG
$29.8B
$10K ﹤0.01%
310
XNCR icon
1035
Xencor
XNCR
$1.44B
$10K ﹤0.01%
260
ITCL
1036
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$10K ﹤0.01%
700
MYOK
1037
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10K ﹤0.01%
198
GHDX
1038
DELISTED
Genomic Health, Inc.
GHDX
$10K ﹤0.01%
192
ANAB icon
1039
AnaptysBio
ANAB
$1.6B
$9K ﹤0.01%
130
DBC icon
1040
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
$9K ﹤0.01%
500
ELP
1041
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$9K ﹤0.01%
4,000
MEDP icon
1042
Medpace
MEDP
$16.8B
$9K ﹤0.01%
208
ARNA
1043
DELISTED
Arena Pharmaceuticals Inc
ARNA
$9K ﹤0.01%
217
AKCA
1044
DELISTED
Akcea Therapeutics Inc
AKCA
$9K ﹤0.01%
368
MNTA
1045
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$9K ﹤0.01%
422
ATRA icon
1046
Atara Biotherapeutics
ATRA
$71.2M
$8K ﹤0.01%
8
CIEN icon
1047
PUT
Ciena
CIEN
$55.3B
$8K ﹤0.01%
2,032
-1,063
-34% -$27K
EDIT icon
1048
Editas Medicine
EDIT
$399M
$8K ﹤0.01%
233
FL
1049
DELISTED
Foot Locker
FL
$8K ﹤0.01%
152
INVA icon
1050
Innoviva
INVA
$1.58B
$8K ﹤0.01%
597

Similar funds

Daiwa Securities Group's Q2 2018 Portfolio in Review

As of Q2 2018, Daiwa Securities Group held 1,215 positions worth $12.7B, up 1.7% from $12.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $755M in Q2 2018, closing 31 positions and reducing 295 holdings. Its most notable exit was Blue Buffalo Pet Products, Inc, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 73% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in VICI Properties worth $115M.

  • Daiwa Securities Group's largest Q2 2018 buy was VICI Properties: 5,575,176 shares worth $115M.
  • Daiwa Securities Group added most to VEREIT, Inc. in Q2 2018, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2018 reduction was Equity Residential, cutting an estimated $189M.
  • Daiwa Securities Group fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $5.82M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $12.7B portfolio in Q2 2018.
  • Daiwa Securities Group opened 45 new positions and closed 31 in Q2 2018.
  • Daiwa Securities Group's portfolio value rose 1.7% quarter-over-quarter to $12.7B.

Based on Daiwa Securities Group's 13F filing for Q2 2018, filed 30 Jul 2018.